The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease

MLA

Mohammad Reza Ganji, et al. “The Establishment and Validation of Novel Therapeutic Targets to Retard Progression of Chronic Kidney Disease.” Kidney International Supplements, vol. 7, Oct. 2017, pp. 130–37. EBSCOhost, https://doi.org/10.1016/j.kisu.2017.07.008.

APA

Mohammad Reza Ganji, Tetsuhiro Tanaka, Bertram L. Kasiske, Anna Zuk, Joseph V. Bonventre, Robyn G Langham, Giuseppe Remuzzi, Chih-Wei Yang, Robert J. Walker, Jerome Rossert, Carol A. Pollock, Yusuke Suzuki, David W. Johnson, Hans-Joachim Anders, & Roberto Pecoits-Filho. (2017). The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease. Kidney International Supplements, 7, 130–137. https://doi.org/10.1016/j.kisu.2017.07.008

Chicago

Mohammad Reza Ganji, Tetsuhiro Tanaka, Bertram L. Kasiske, Anna Zuk, Joseph V. Bonventre, Robyn G Langham, Giuseppe Remuzzi, et al. 2017. “The Establishment and Validation of Novel Therapeutic Targets to Retard Progression of Chronic Kidney Disease.” Kidney International Supplements 7 (October): 130–37. doi:10.1016/j.kisu.2017.07.008.